The number of Covid-19 Johnson & Johnson vaccines allocated to states and other jurisdictions by the federal government is expected to drop 84% next week, according to data from the United States Centers for Disease Control and Prevention.
This week, nearly 5 million doses of the Johnson & Johnson vaccine have been allocated to states and other jurisdictions, but only about 785,000 are scheduled for next week.
Pfizer / BioNTech and Moderna vaccine allocations for next week, however, will remain stable from this week. About 4.7 million first doses of Pfizer and 3.5 million first doses of Moderna have been allocated for next week, along with the corresponding second doses.
The Pfizer / BioNTech and Moderna vaccine allocations have been largely consistent from week to week. However, the weekly Johnson & Johnson vaccine allocations have varied widely.
According to CDC data, the first Johnson & Johnson vaccine allocation – for the week of March 1 – included more than 2.8 million doses. No Johnson & Johnson vaccine allowance was recorded for the week of March 8, and the allowance fell to less than 500,000 doses for the next two weeks. Then, for the week of March 29, allocations rose to nearly $ 2 million, before more than doubling for that week.
Here are the total allocations for the Johnson & Johnson vaccine to states and other jurisdictions each week, according to CDC data:
- Week of March 1: 2 833 400
- Week of March 8: nothing
- Week of March 15: 493 700
- Week of March 22: 389 900
- Week of March 29: 1 911 200
- Week of April 5: 4 947 500
- Week of April 12: 785 500
About 4.5 million people have been vaccinated with the Johnson & Johnson vaccine, or about 7% of people fully vaccinated in the United States, according to the latest data from the CDC.